Cryoport Inc (OTCBB: CYRX) has reached agreement with Zoetis Inc (formerly the animal health business unit of Pfizer Inc) to expand the scope of the cold chain logistics services Cryoport is providing.
In December 2012, Cryoport signed an agreement with Pfizer relating to Zoetis to manage frozen shipments of a key poultry vaccine. Under this arrangement, Cryoport is providing on-site logistics personnel and its logistics management platform, the Cryoportal, to manage shipments from the Zoetis manufacturing site in the United States to domestic customers as well as selected international distribution centers.
As part of its logistics management services, Cryoport analyzes shipping data and processes to further streamline Zoetis’ logistics, ensuring products arrive at destinations in specified conditions, on time, and with optimum uses of resources. Initially, Cryoport managed Pfizer’s total fleet of dewar flask shippers used for this purpose, including liquid nitrogen shippers.
In the amended agreement, Cryoport’s scope is expanded to manage all domestic shipments of the key frozen poultry vaccine as well as all shipments of this vaccine to all Zoetis’ international distribution centers.
Cryoport provides frozen shipping logistics systems to the biotechnology and life science industries through the combination of purpose-built proprietary hardware and software technologies and total turnkey management of the entire logistics process.
For more information, visit www.cryoport.com.